These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33534536)

  • 1. Protein Synthesis and Degradation Inhibitors Potently Block
    Drever K; Lim ZL; Zriba S; Chen JM
    ACS Infect Dis; 2021 Feb; 7(2):273-280. PubMed ID: 33534536
    [No Abstract]   [Full Text] [Related]  

  • 2. IMB-BZ as an Inhibitor Targeting ESX-1 Secretion System to Control Mycobacterial Infection.
    Jia P; Zhang Y; Xu J; Zhu M; Peng S; Zhang Y; Zhao J; Li X; Mi K; Yan D; Wang Y; Yu L; Lu Y; Shi H; Cen S
    J Infect Dis; 2022 Feb; 225(4):608-616. PubMed ID: 34558604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A New ESX-1 Substrate in Mycobacterium marinum That Is Required for Hemolysis but Not Host Cell Lysis.
    Bosserman RE; Nicholson KR; Champion MM; Champion PA
    J Bacteriol; 2019 Jul; 201(14):. PubMed ID: 30833360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycobacterium tuberculosis Toxin CpnT Is an ESX-5 Substrate and Requires Three Type VII Secretion Systems for Intracellular Secretion.
    Izquierdo Lafuente B; Ummels R; Kuijl C; Bitter W; Speer A
    mBio; 2021 Mar; 12(2):. PubMed ID: 33653883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling Tubercular ESX-1 Secretion Using Mycobacterium marinum.
    Chirakos AE; Balaram A; Conrad W; Champion PA
    Microbiol Mol Biol Rev; 2020 Nov; 84(4):. PubMed ID: 32878966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modular Organization of the ESX-5 Secretion System in Mycobacterium tuberculosis.
    Shah S; Briken V
    Front Cell Infect Microbiol; 2016; 6():49. PubMed ID: 27200304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The plasmid-mediated evolution of the mycobacterial ESX (Type VII) secretion systems.
    Newton-Foot M; Warren RM; Sampson SL; van Helden PD; Gey van Pittius NC
    BMC Evol Biol; 2016 Mar; 16():62. PubMed ID: 26979252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polarly Localized EccE
    Soler-Arnedo P; Sala C; Zhang M; Cole ST; Piton J
    J Bacteriol; 2020 Feb; 202(5):. PubMed ID: 31843799
    [No Abstract]   [Full Text] [Related]  

  • 9. Mycobacterium tuberculosis EspK Has Active but Distinct Roles in the Secretion of EsxA and EspB.
    Lim ZL; Drever K; Dhar N; Cole ST; Chen JM
    J Bacteriol; 2022 Apr; 204(4):e0006022. PubMed ID: 35315684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ESX/type VII secretion systems of mycobacteria: Insights into evolution, pathogenicity and protection.
    Simeone R; Bottai D; Frigui W; Majlessi L; Brosch R
    Tuberculosis (Edinb); 2015 Jun; 95 Suppl 1():S150-4. PubMed ID: 25732627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antagonistic transcription factors, EspM and EspN, regulate the ESX-1 secretion system in
    Nicholson KR; Cronin RM; Prest RJ; Menon AR; Yang Y; Jennisch MK; Champion MM; Tobin DM; Champion PA
    mBio; 2024 Apr; 15(4):e0335723. PubMed ID: 38445877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation of
    Ho VQT; Rong MK; Habjan E; Bommer SD; Pham TV; Piersma SR; Bitter W; Ruijter E; Speer A
    Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species-specific secretion of ESX-5 type VII substrates is determined by the linker 2 of EccC
    Bunduc CM; Ummels R; Bitter W; Houben ENG
    Mol Microbiol; 2020 Jul; 114(1):66-76. PubMed ID: 32096294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conserved ESX-1 Substrates EspE and EspF Are Virulence Factors That Regulate Gene Expression.
    Chirakos AE; Nicholson KR; Huffman A; Champion PA
    Infect Immun; 2020 Nov; 88(12):. PubMed ID: 32900815
    [No Abstract]   [Full Text] [Related]  

  • 15. Phosphate starvation: a novel signal that triggers ESX-5 secretion in Mycobacterium tuberculosis.
    Elliott SR; Tischler AD
    Mol Microbiol; 2016 May; 100(3):510-26. PubMed ID: 26800324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ESX-3 secretion system in Mycobacterium: An overview.
    Granados-Tristán AL; Hernández-Luna CE; González-Escalante LA; Camacho-Moll ME; Silva-Ramírez B; Bermúdez de León M; Peñuelas-Urquides K
    Biochimie; 2024 Jan; 216():46-55. PubMed ID: 37879428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting type VII/ESX secretion systems for development of novel antimycobacterial drugs.
    Bottai D; Serafini A; Cascioferro A; Brosch R; Manganelli R
    Curr Pharm Des; 2014; 20(27):4346-56. PubMed ID: 24245757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intragranuloma Accumulation and Inflammatory Differentiation of Neutrophils Underlie Mycobacterial ESX-1-Dependent Immunopathology.
    Lienard J; Munke K; Wulff L; Da Silva C; Vandamme J; Laschanzky K; Joeris T; Agace W; Carlsson F
    mBio; 2023 Apr; 14(2):e0276422. PubMed ID: 37017530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterial Virulence Factors: Surface-Exposed Lipids and Secreted Proteins.
    Ly A; Liu J
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32498243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infect and Inject: How
    Tiwari S; Casey R; Goulding CW; Hingley-Wilson S; Jacobs WR
    Microbiol Spectr; 2019 May; 7(3):. PubMed ID: 31172908
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.